About Nexien BioPharma
Nexien BioPharma is a company based in Denver (United States) founded in 1952 by Richard S Greenberg. It operates as a Professional Services, Licensing Model, and HealthTech. Nexien BioPharma has completed 1 acquisition, including CRX Bio. Nexien BioPharma offers products and services including Cannabinoid Medications, Delivery Systems, and Investment in Cannabinoid Research. Nexien BioPharma operates in a competitive market with competitors including MediPharm Labs, Holistic Industries, Motif Labs, Vertosa and FarmaceuticalRX, among others.
- Headquarter Denver, United States
- Founders Richard S Greenberg
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nexien Biopharma Inc
-
Annual Revenue
-
Net Profit
$-239.11 K33.93as on Jun 30, 2024
-
EBITDA
$-155.66 K44.92as on Jun 30, 2024
-
Latest Funding Round
$1.4 M (USD), Post-IPO
Nov 29, 2017
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nexien BioPharma
Nexien BioPharma offers a comprehensive portfolio of products and services, including Cannabinoid Medications, Delivery Systems, and Investment in Cannabinoid Research. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Cannabinoid-based drugs are developed for medical conditions.
Proprietary systems are created for cannabinoid medication delivery.
Investments are made in cannabinoid research technologies.
Unlock access to complete
Funding Insights of Nexien BioPharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $1.4M
-
First Round
First Round
(29 Nov 2017)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2017 | Amount | Post-IPO - Nexien BioPharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Nexien BioPharma
Nexien BioPharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CRX Bio. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cannabis research and development services are provided to clients.
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Nexien BioPharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nexien Biopharma Comparisons
Competitors of Nexien BioPharma
Nexien BioPharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediPharm Labs, Holistic Industries, Motif Labs, Vertosa and FarmaceuticalRX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical-grade cannabinoid products and APIs are manufactured.
|
|
| domain | founded_year | HQ Location |
Proprietary medical cannabis strains are developed and offered.
|
|
| domain | founded_year | HQ Location |
Cannabinoid extraction, purification, and formulation services are provided.
|
|
| domain | founded_year | HQ Location |
Technology for active ingredients from infused hemp is provided.
|
|
| domain | founded_year | HQ Location |
Cannabis-based products including flower and concentrates are manufactured and supplied.
|
|
| domain | founded_year | HQ Location |
Oral cannabis-based healthcare products are developed for therapeutic treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nexien Biopharma
Frequently Asked Questions about Nexien BioPharma
When was Nexien BioPharma founded?
Nexien BioPharma was founded in 1952 and raised its 1st funding round 65 years after it was founded.
Where is Nexien BioPharma located?
Nexien BioPharma is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
Who is the current CEO of Nexien BioPharma?
Richard S Greenberg is the current CEO of Nexien BioPharma. They have also founded this company.
What does Nexien BioPharma do?
Nexien BioPharma is focused on the research and development of cannabinoid-based pharmaceuticals in compliance with United States Food and Drug Administration (FDA) regulatory pathways. Operations are conducted with DEA-licensed clinical research organizations, contract manufacturing partners, and academic institutions. The company pursues three synergistic paths: developing and licensing cannabinoid medications for specific medical conditions, creating proprietary delivery systems for accurate dosing, and investing in cannabinoid research technologies through special purpose vehicles. Activities are centered in the healthcare sector with an emphasis on innovative drug solutions.
Who are the top competitors of Nexien BioPharma?
Nexien BioPharma's top competitors include Holistic Industries, MediPharm Labs and FarmaceuticalRX.
What products or services does Nexien BioPharma offer?
Nexien BioPharma offers Cannabinoid Medications, Delivery Systems, and Investment in Cannabinoid Research.
How many acquisitions has Nexien BioPharma made?
Nexien BioPharma has made 1 acquisition, including CRX Bio.